Company / Inventory
Supernus Pharmaceuticals, Inc. Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$112.5M
FY2025
5-year range
$54.3M / $112.5M
FY2021-FY2025
Trend
+107.2%
vs FY2024
Sector context
#42 of 105
Health Care
What the data says
At $112M, Supernus Pharmaceuticals, Inc.'s inventory ranks #42 of 105 in the Health Care sector. Inventory returned to growth in FY2025 after 2 years of decline, reaching $112M.
Based on SEC 10-K filings.
$112M in FY2025 with a 5-year CAGR of +18.4%.
Improved from $77M to $112M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +7.1%
- 5-Year CAGR
- +18.4%
- 10-Year CAGR
- -
Sector benchmark
#42 of 105 in Health CareTop 40% of 105This company $112.5M Sector average $885.3M
▼
-87.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +18.4%, indicating consistent growth.
- In FY2025, inventory increased 107.2% year-over-year.
- Ranks #42 out of 105 companies in the Health Care sector.
- Lowest inventory in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $112.5M | +107.2% |
| FY2024 | $54.3M | -29.9% |
| FY2023 | $77.4M | -15.4% |
| FY2022 | $91.5M | +6.5% |
| FY2021 | $86.0M | +77.9% |
| FY2020 | $48.3M | +81.5% |
| FY2019 | $26.6M | +3.8% |
| FY2018 | $25.7M | +57.4% |
| FY2017 | $16.3M | -3.0% |
| FY2016 | $16.8M | +33.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026